Published in Shock on September 01, 2002
A phase 1 trial of nebulised heparin in acute lung injury. Crit Care (2008) 1.24
Airway obstruction due to bronchial vascular injury after sulfur mustard analog inhalation. Am J Respir Crit Care Med (2010) 1.06
Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial. Crit Care (2010) 0.97
Airway tissue factor-dependent coagulation activity in response to sulfur mustard analog 2-chloroethyl ethyl sulfide. Am J Physiol Lung Cell Mol Physiol (2011) 0.97
A neutrophil elastase inhibitor, sivelestat, reduces lung injury following endotoxin-induced shock in rats by inhibiting HMGB1. Inflammation (2008) 0.93
Nebulized anticoagulants for acute lung injury - a systematic review of preclinical and clinical investigations. Crit Care (2012) 0.86
Effects of biliverdin administration on acute lung injury induced by hemorrhagic shock and resuscitation in rats. PLoS One (2013) 0.86
Galangin dampens mice lipopolysaccharide-induced acute lung injury. Inflammation (2014) 0.85
Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats. Crit Care (2008) 0.84
Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-κB signaling pathways. Sci Rep (2016) 0.83
Wood bark smoke induces lung and pleural plasminogen activator inhibitor 1 and stabilizes its mRNA in porcine lung cells. Shock (2011) 0.83
Intratracheal heparin improves plastic bronchitis due to sulfur mustard analog. Pediatr Pulmonol (2014) 0.83
Activation of PPARα by Wy-14643 ameliorates systemic lipopolysaccharide-induced acute lung injury. Biochem Biophys Res Commun (2013) 0.82
Attenuation of hyperoxia-induced lung injury in rats by adrenomedullin. Inflammation (2012) 0.82
High-dose antithrombin III prevents heat stroke by attenuating systemic inflammation in rats. Inflamm Res (2010) 0.81
Continuous hemodiafiltration therapy reduces damage of multi-organs by ameliorating of HMGB1/TLR4/NFκB in a dog sepsis model. Int J Clin Exp Pathol (2015) 0.80
Carrageenan inhibits granzyme A-induced detachment of and interleukin-8 release from alveolar epithelial A549 cells. Cytotechnology (2008) 0.79
Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort study. BMC Pulm Med (2012) 0.79
A novel anti-histone H1 monoclonal antibody, SSV monoclonal antibody, improves lung injury and survival in a mouse model of lipopolysaccharide-induced sepsis-like syndrome. Biomed Res Int (2015) 0.78
The new vitamin E derivative, ETS-GS, protects against cecal ligation and puncture-induced systemic inflammation in rats. Inflammation (2012) 0.78
Treatment of low molecular weight heparin inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats. Inflammation (2014) 0.77
Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injury. Thorax (2007) 0.77
Pharmaco-management of inhalation injuries for burn survivors. Drug Des Devel Ther (2009) 0.76
Human atrial natriuretic peptide ameliorates LPS-induced acute lung injury in rats. Lung (2010) 0.76
Effect of dobutamine on lung aquaporin 5 in endotoxine shock-induced acute lung injury rabbit. J Thorac Dis (2015) 0.75
Nebulised heparin: a new approach to the treatment of acute lung injury? Crit Care (2008) 0.75
Evidence of altered haemostasis in an ovine model of venovenous extracorporeal membrane oxygenation support. Crit Care (2017) 0.75
Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74
A genomic storm in critically injured humans. J Exp Med (2011) 6.67
Pathophysiologic response to severe burn injury. Ann Surg (2008) 3.73
Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A (2005) 3.49
American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res (2007) 2.71
Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A (2009) 2.66
Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One (2011) 2.58
Cytokine expression profile over time in severely burned pediatric patients. Shock (2006) 2.33
Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity (2004) 2.29
CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J Immunol (2004) 2.25
Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock. Crit Care Med (2010) 2.22
Preclinical evaluation of epinephrine nebulization to reduce airway hyperemia and improve oxygenation after smoke inhalation injury. Crit Care Med (2011) 2.10
Long-term posttraumatic stress symptoms vary inversely with early opiate dosing in children recovering from serious burns: effects durable at 4 years. J Trauma Acute Care Surg (2014) 2.03
Impaired zinc and copper status in children with burn injuries: need to reassess nutritional requirements. Burns (2005) 1.98
Burn size determines the inflammatory and hypermetabolic response. Crit Care (2007) 1.97
A novel animal model of sepsis after acute lung injury in sheep. Crit Care Med (2002) 1.95
Extravascular lung water determined with single transpulmonary thermodilution correlates with the severity of sepsis-induced acute lung injury. Crit Care Med (2006) 1.85
Glucose control in severely thermally injured pediatric patients: what glucose range should be the target? Ann Surg (2010) 1.78
Blood transfusions are associated with increased risk for development of sepsis in severely burned pediatric patients. Crit Care Med (2007) 1.77
Combined burn and smoke inhalation injury impairs ovine hypoxic pulmonary vasoconstriction. Crit Care Med (2006) 1.77
Synthesis of vitamin D in skin after burns. Lancet (2004) 1.75
Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children. Pediatr Crit Care Med (2008) 1.73
Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab (2009) 1.71
Combined neuronal and inducible nitric oxide synthase inhibition in ovine acute lung injury. Crit Care Med (2009) 1.68
Role of selective V1a receptor agonism in ovine septic shock. Crit Care Med (2011) 1.68
Temporal cytokine profiles in severely burned patients: a comparison of adults and children. Mol Med (2008) 1.67
Morbidity and survival probability in burn patients in modern burn care. Crit Care Med (2015) 1.67
Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med (2002) 1.66
Low-dose terlipressin for hemodynamic support in sepsis and systemic inflammatory response syndrome: art for (he)art's sake or state of the art? Crit Care Med (2005) 1.65
Desmoplastic small round cell tumor of the lung. Arch Pathol Lab Med (2002) 1.65
Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis. Shock (2003) 1.64
Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med (2007) 1.62
Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol (2005) 1.62
Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg (2004) 1.61
The influence of age and gender on resting energy expenditure in severely burned children. Ann Surg (2006) 1.60
Influence of systemic inflammatory response syndrome on host resistance against bacterial infections. Crit Care Med (2004) 1.59
Serum cytokine differences in severely burned children with and without sepsis. Shock (2007) 1.59
The leading causes of death after burn injury in a single pediatric burn center. Crit Care (2009) 1.59
Airway obstruction in sheep with burn and smoke inhalation injuries. Am J Respir Cell Mol Biol (2003) 1.58
Benchmarking outcomes in the critically injured burn patient. Ann Surg (2014) 1.58
Prediction of mortality from catastrophic burns in children. Lancet (2003) 1.58
Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children. Crit Care Med (2002) 1.58
Hypoglycemia is associated with increased postburn morbidity and mortality in pediatric patients. Crit Care Med (2014) 1.58
Emerging infections in burns. Surg Infect (Larchmt) (2009) 1.57
Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury. Crit Care Med (2009) 1.57
Skin nitric oxide and its metabolites are increased in nonburned skin after thermal injuries. Shock (2004) 1.56
Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am J Respir Crit Care Med (2010) 1.53
The effect of growth hormone on gut mucosal homeostasis and cellular mediators after severe trauma. J Surg Res (2005) 1.52
Continuous nebulized albuterol attenuates acute lung injury in an ovine model of combined burn and smoke inhalation. Crit Care Med (2006) 1.52
Evidence supporting a role of glucocorticoids in short-term bone loss in burned children. Osteoporos Int (2004) 1.52
Body composition changes with time in pediatric burn patients. J Trauma (2006) 1.49
A genomic score prognostic of outcome in trauma patients. Mol Med (2009) 1.48
Cardiopulmonary effects of low-dose arginine vasopressin in ovine acute lung injury. Crit Care Med (2011) 1.47
Pivotal advance: glycyrrhizin restores the impaired production of beta-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas aeruginosa wound infection. J Leukoc Biol (2009) 1.46
Intensive insulin therapy improves insulin sensitivity and mitochondrial function in severely burned children. Crit Care Med (2010) 1.46
Extravascular lung water assessed by transpulmonary single thermodilution and postmortem gravimetry in sheep. Crit Care (2004) 1.45
Dietary fat composition alters pulmonary function in pigs. Nutrition (2002) 1.45
Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor. Crit Care Med (2012) 1.44
IGF-I gene transfer effects on inflammatory elements present after thermal trauma. Am J Physiol Regul Integr Comp Physiol (2003) 1.43
The effect of hepatocyte growth factor on gut mucosal apoptosis and proliferation, and cellular mediators after severe trauma. Surgery (2005) 1.42